In a fresh round of patent battle over the launch of generic drugs in the US market, domestic pharmaceutical majors Orchid, Sun Pharma and Ranbaxy Laboratories have been sued by Cima Labs, Otsuka Pharmaceutical Co and Abbott Laboratories, respectivel
Both Indian and MNC IT majors are hiring big time, expressing their confidence in the Indian economy and outsourcing/offshoring growth story.
Fortis Healthcare, promoted by the Singh family of Ranbaxy, plans to expand its network to 40 hospitals within three years by either acquiring new facilities or setting up greenfield projects
Beer is gaining more popularity in some of the non-traditional beer markets in North India like Rajasthan, Punjab, Delhi and Uttar Pradesh.
Amgen, the world's largest biotechnology company, has entered India by opening a wholly owned subsidiary Amgen Technology in Mumbai.
Motorola, the world's second largest mobile manufacturer in the world, plans to continue to offer cheaper phones in the emerging markets even as there are reports that it may register losses in its first-quarter results and cut its sales forecast.
Cellphone users are unaware that there are almost 200 viruses that can get into their phones, and wipe out the entire address book, data and music files while they perform an everyday tasks.
Mumbai-based Advanced Enzyme Technologies Ltd, the largest manufacturer of enzymes in the country, will invest Rs 115 crore to set up three biotech production facilities.
With the bidding for the generics business of Merck set to begin from Monday, domestic pharmaceutical companies in the fray, Ranbaxy Laboratories and Dr Reddy's Laboratories, are unlikely to go for an all-out bidding war.
Spectrum Retail Mart, a retail chain of medical stores and fast moving consumer goods, has set up shop in Mumbai with an initial investment of over Rs 90 crore (Rs 900 million).
The current level of automation available in the Indian call centre industry is very rudimentary with only the language assistance interface or the first level of the call being automated.
After being raided by Federal officials, Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, has been taken to court in the US by a consumer health group that supports the sale of low-priced generic medicines.
The Indian company that acquires Merck Generics, the multinational drug maker's generics (non-patented) business, up for sale, will be able to compete against the top global players
Mumbai-based pharmaceutical company Indoco Remedies Ltd plans to tap the regulated markets of Europe and the US.
In Mumbai, Reliance Health Venture has already acquired the Mandke hospital, which will be converted into a 650-bed super specialty hospital with six divisions.
As many as 15 companies across the world have lined up generic variants of Pfizer's Zoloft (Sertaline HCL), for which the exclusive six-month marketing period granted to the successful patent challenger, Teva of Israel, ends on Tuesday.
A professor feels the use of chips among patients can do wonders but he also believes the usage should not be restricted to therapeutic use only.
It is too late to devote resources to chip manufacturing. India, instead, should explore opportunities in solar energy, where entry barriers are low and end-products are sold like commodity, states a JP Morgan report.
Thousands of robots which were confined to research labs in India, are now finding their way into schools and engineering colleges.
The Mumbai marathon is set to embrace technology.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances